Showing results (2531-2540 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|June 24, 2015
Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?Jonathan Karnon, Andrew Partington
Pharmacoeconomics|June 25, 2015
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for PracticeJames F O'Mahony, Anthony T Newall, Joost van Rosmalen
Pharmacoeconomics|August 29, 2025
Developing an EQ-5D-5L Value Set for SingaporeNan Luo, Annushiah Vasan Thakumar, Ling Jie Cheng, et al.
Pharmacoeconomics|June 10, 2015
The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety LitigationAnita Chawla, Ginger Carls, Edmund Deng, et al.
Pharmacoeconomics|June 7, 2015
Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic AssessmentsNeily Zakiyah, Maarten J Postma, Philip N Baker, et al.
Pharmacoeconomics|June 12, 2015
Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its ComplicationsAmarpreet S Chawla, Chia-Wen Hsiao, Martha C Romney, et al.
Pharmacoeconomics|January 21, 2018
Cost Effectiveness of Treatments for Chronic Constipation: A Systematic ReviewDolly Han, Nicolas Iragorri, Fiona Clement, et al.
Pharmacoeconomics|October 30, 2017
A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity AnalysisShijie Ren, Jonathan Minton, Sophie Whyte, et al.
Pharmacoeconomics|March 28, 2018
Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology AppraisalKeith Cooper, Geoff Frampton, Petra Harris, et al.
Pharmacoeconomics|March 8, 2018
Using Discrete-Choice Experiment Methods to Estimate the Value of Informal Care: The Case of Children with Intellectual DisabilitySheena Arora, Stephen Goodall, Rosalie Viney, et al.
Pageof 336